Anthropic’s IPO Puts AI’s Promise, Peril and Price Tag on the Same Prospectus
Anthropic’s IPO Puts AI’s Promise, Peril and Price Tag on the Same Prospectus
Anthropic began the public phase of its IPO push on Monday, filing an S-1 registration statement with the SEC for Class A shares it plans to list on Nasdaq under the ticker ANT. The company has not yet set a share count or price range, and stressed that the registration statement is not yet effective.
The filing follows confidential paperwork submitted in June and arrives as the company behind Claude races toward a potential Thanksgiving-week debut. One account framed the deal as more than a routine flotation: a likely “referendum on the business of AI,” with speculation placing a potential valuation between $1.5 trillion and $2 trillion.
The numbers explain both the excitement and the unease. Anthropic reported $16.3 billion in first-half 2026 revenue, up from $1.2 billion a year earlier, alongside an $80.7 billion net loss. Yet the bulk of that headline loss — $72.4 billion — reflected an accounting charge connected to convertible notes; operating losses narrowed to $693 million, while adjusted operating income reached $1.6 billion and operating cash flow turned positive.
Anthropic’s own case is emphatically long-term. “We believe that AI is one of the most consequential technologies in human history,” it wrote, arguing the technology could accelerate scientific discovery, growth and disease cures — if its risks are managed well. That ambition comes with an extraordinary infrastructure bill: the filing details commitments including up to $120.5 billion for SpaceX GPU access by 2029, plus major spending agreements with Microsoft, Google and Amazon.
But the prospectus does not present safety as a footnote. It warns that advanced systems could pose “catastrophic or existential risks to humanity” if misused, weaponized or allowed too much autonomy. It also discloses reliance on a small group of customers and cloud marketplaces run by companies that compete with it.
Finally, public investors will be buying into limited control. Anthropic’s seven co-founders, through a Founder LLC, will retain 50.1% of voting power, while its Long-Term Benefit Trust can appoint most directors — safeguards the company says preserve its safety mission, but a structure critics see as leaving ordinary shareholders with little practical say.
Write a comment